$3.20
-0.05-1.54%
Last update: Nov 4, 4:00 PM
MiMedx Group Inc
MDXGNASDAQ
The average analyst price target for MiMedx Group is $9.29, 189.4% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $6 to $12. The latest change came on Aug 27, 2026, when Craig-Hallum raised its price target on MiMedx Group from $6 to $8 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
